StemCell Technologies is a world leader in the development of products for stem cell biology and has worked to standardize the field through the Global Proficiency Testing Program. Combining StemCell Technologies' industry standard reagents and a scientific team of experts in hematopoiesis and stem cell biology, the company is proud to assist organizations in drug development, agrochemical production, environmental toxicant testing and the research community by offering Contract Assay Services.
- (20.09.2017) STEMCELL Technologies Signs Exclusive License with Propagenix to Commercialize EpiX, an Innovation Empowering Epithelial Cell Biology and Cell Therapy
- (18.04.2017) Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies
- (31.01.2017) STEMCELL Technologies Opens New Office and Laboratories in Cambridge, UK
- (09.06.2015) STEMCELL Technologies Named Company of the Year by BIOTECanada
- (08.05.2013) STEMCELL Technologies Inc. Obtains License from iPS Academia Japan for Induced Pluripotent Stem Cell Technologies
- (16.09.2010) Commercial Partnership with STEMCELL Technologies Inc
- (17.08.2009) BioLife Solutions, Inc. (BLFS.OB) and StemCell Technologies Inc. Announce Worldwide Distribution Agreement